Related Experiment Video
Updated: Aug 14, 2026
05:49
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Colposcopically directed punch biopsy: a potentially misleading investigation
E J Buxton1, D M Luesley, M I Shafi
1University of Birmingham Department of Obstetrics and Gynaecology, Dudley Road Hospital, UK.
British Journal of Obstetrics and Gynaecology
|December 1, 1991
Summary
Cervical punch biopsies often misjudge lesion severity compared to loop excision. Punch biopsies are inadequate for determining epithelial lesion severity, impacting patient management and trial design.
Area of Science:
- Gynecologic Oncology
- Cervical Pathology
- Colposcopy
Background:
- Colposcopically directed punch biopsy is a standard initial diagnostic procedure for cervical epithelial abnormalities.
- Loop diathermy excision is a common treatment for cervical intraepithelial neoplasia (CIN).
Purpose of the Study:
- To evaluate the concordance between punch biopsy histology and loop diathermy excision histology of the cervical transformation zone.
- To assess the influence of lesion size on the diagnostic accuracy of punch biopsies.
Main Methods:
- Prospective observational study involving 243 women undergoing loop diathermy excision of the cervical transformation zone.
- Histological comparison of initial punch biopsies with subsequent loop excision specimens.
- Analysis of lesion size in relation to histological findings.
Main Results:
- Histological agreement between punch biopsy and loop excision was observed in only 46% of cases.
- More severe lesions, including adenocarcinoma in situ and early-stage cancer, were found in 47% of discordant loop excision specimens.
- Punch biopsies underestimated lesion severity in 41% of CIN 3 or higher lesions.
- Small lesions were more likely to be underestimated by punch biopsy (P = 0.0014).
Conclusions:
- Cervical punch biopsy is an unreliable method for assessing the true severity of epithelial lesions.
- These findings necessitate a re-evaluation of patient management strategies and clinical trial designs that rely on punch biopsy data.
- The results question the validity of previous studies utilizing punch biopsy as a primary endpoint.
